![The Lancet Gastroenterology & Hepatology in conversation with artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts115/v4/bd/90/74/bd907461-84c1-edd1-5ff2-da3f890b4b3b/mza_50384648226739081.jpg/100x100bb.jpg)
A new drug for short bowel syndrome
The Lancet Gastroenterology & Hepatology in conversation with
English - April 05, 2019 22:30 - 11 minutes - 7.03 MBLife Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Eosinophilic oesophagitis endotype classification
Next Episode: Whole-body MRI: the STREAMLINE trials
Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv